Načítá se...

Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma

OBJECTIVE: To evaluate the performance of the nuclear matrix protein 22 (NMP22) BladderChek test in urothelial carcinoma (UC). METHODS: We retrospectively analyzed 1318 patients who performed the NMP22 BladderChek tests. Of them, 103 were primary UC patients, 90 were surgical treatment UC patients,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Dis Markers
Hlavní autoři: Xia, Chang-sheng, Fan, Chun-hong, Su, Ming, Wang, Qing-song, Bao, Hui-zhang
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7232672/
https://ncbi.nlm.nih.gov/pubmed/32454904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3424039
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!